KORU Medical CCO reports RSU vesting and tax

KORU Medical Systems, Inc. reported that Chief Commercial Officer Adam R. Kalbermatten had 75,000 shares of common stock delivered on July 28, 2026 upon vesting of previously granted restricted stock units, each converting into one share.

Rhea-AI Filing Summary

KORU Medical Systems, Inc. reported that Chief Commercial Officer Adam R. Kalbermatten had 75,000 shares of common stock delivered on July 28, 2026 upon vesting of previously granted restricted stock units, each converting into one share. On the same date, 25,483 shares were withheld at $4.26 per share to satisfy tax obligations related to the vesting. The transactions were reported as direct holdings and not under a Rule 10b5-1 trading plan.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider KALBERMATTEN ADAM R

Role Chief Commercial Officer

Type	Security	Shares	Price	Value
Exercise	Common Stock F1	75,000	$0.00	$0.00
Tax Withholding	Common Stock F2	25,483	$4.26	$109K

Holdings After Transaction: Common Stock — 362,017 shares (Direct)

Footnotes (2)

1. F1. Represents shares of common stock delivered upon vesting of previously granted restricted stock units. Each restricted stock unit converts to one share of common stock upon vesting.
2. F2. Represents shares withheld to satisfy tax obligations upon vesting of restricted stock units.

Key Figures

Shares acquired via RSU vesting: 75,000 shares of common stock Shares withheld for taxes: 25,483 shares of common stock Tax withholding price: $4.26 per share

3 metrics

Shares acquired via RSU vesting 75,000 shares of common stock Delivered on July 28, 2026 upon vesting of previously granted restricted stock units

Shares withheld for taxes 25,483 shares of common stock Withheld on July 28, 2026 to satisfy tax obligations upon RSU vesting

Tax withholding price $4.26 per share Per-share value used for shares withheld to satisfy tax obligations

Key Terms

restricted stock units, beneficial owner, Section 16 of the Securities Exchange Act of 1934, Power of Attorney

4 terms

restricted stock units financial

"Represents shares of common stock delivered upon vesting of previously granted restricted stock units."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

beneficial owner regulatory

"shall not be construed as an admission ... the beneficial owner of any equity securities"

A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.

Section 16 of the Securities Exchange Act of 1934 regulatory

"for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended"

A provision of federal securities law that requires company insiders—directors, officers and large shareholders—to publicly report their stock holdings and trades and to surrender any “short-swing” profits from purchases and sales within a six-month window. It acts like a rule that forces leaders to announce their trades and prevents quick buy-sell windfalls, giving investors transparency into insider activity and reducing opportunities for unfair gain.

Power of Attorney regulatory

"Power of Attorney has been previously filed."

A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider equity transaction did KORU Medical Systems (KRMD) disclose for its CCO?

KORU Medical Systems (KRMD) disclosed that its Chief Commercial Officer, Adam R. Kalbermatten, received 75,000 shares of common stock on July 28, 2026 from the vesting of previously granted restricted stock units, with a separate share withholding to cover associated tax obligations.

How many KORU Medical (KRMD) shares vested for Adam R. Kalbermatten and from what award type?

Adam R. Kalbermatten received 75,000 shares of KORU Medical common stock from the vesting of previously granted restricted stock units. Each restricted stock unit converted into one share of common stock upon vesting, according to the Form 4 footnote.

How many KORU Medical (KRMD) shares were withheld for taxes and at what price?

To satisfy tax obligations upon RSU vesting, 25,483 shares of KORU Medical common stock were withheld at a price of $4.26 per share. This withholding was reported as a disposition coded as a tax-liability transaction.

Were the KORU Medical (KRMD) insider transactions reported under a Rule 10b5-1 plan?

No. The filing’s Rule 10b5-1 checkbox is unchecked, indicating the reported transactions for Adam R. Kalbermatten on July 28, 2026 were not affirmed as being executed pursuant to a Rule 10b5-1 trading plan or similar pre-arranged trading arrangement.

What does the Form 4 say about the nature of Adam R. Kalbermatten’s ownership in KRMD?

The Form 4 reports the transactions as direct ownership of KORU Medical common stock. A remark clarifies the filing should not be construed as an admission that Adam R. Kalbermatten is the beneficial owner of the equity securities covered for Section 16 purposes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/06/2026 - 04:12 PM Accepted by SEC EDGAR 08/06/2026 - 04:11 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KALBERMATTEN ADAM R

(Last) (First) (Middle)

C/O KORU MEDICAL SYSTEMS, INC.

100 CORPORATE DRIVE

(Street)

MAHWAH NEW JERSEY 07430

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
KORU Medical Systems, Inc. [ KRMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/28/2026		M		75,000(1)	A	$0	387,500	D
Common Stock	07/28/2026		F(2)		25,483	D	$4.26	362,017	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of common stock delivered upon vesting of previously granted restricted stock units. Each restricted stock unit converts to one share of common stock upon vesting.

2. Represents shares withheld to satisfy tax obligations upon vesting of restricted stock units.

Remarks:

The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person. Power of Attorney has been previously filed.

	/s/ Thomas Edward Adams - Attorney-in-Fact	08/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)